(Total Views: 739)
Posted On: 12/16/2021 8:39:08 AM
Post# of 154089
This will be the new paper being submitted to a peer reviewed journal -
Quote:
"Suppression of Immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species. Chang XL, Reed JS, Webb GM, Wu HL, Le J, Bateman KB, Greene JM, Pessoa C, Hwang J, FischerM, Moats C, ShielO, BochartR, Crank H, SiessD, GiobbiT, Torgerson J, AgnorR, GaoL, Dhody K, LalezariJP, Kelly S, Pourhassan N, Smedley J, BimberBN, Hansen SG, Ndhlovu LC, Sacha JB. Manuscript in preparation
https://www.questclinical.com/_files/ugd/2a39...26fa89.pdf
(8)
(0)
